chr21-33621997-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145858.3(CRYZL1):c.216T>A(p.Asp72Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000215 in 1,597,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145858.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRYZL1 | ENST00000381554.8 | c.216T>A | p.Asp72Glu | missense_variant, splice_region_variant | Exon 4 of 13 | 1 | NM_145858.3 | ENSP00000370966.3 | ||
CRYZL1 | ENST00000381540.7 | c.216T>A | p.Asp72Glu | missense_variant, splice_region_variant | Exon 4 of 13 | 2 | ENSP00000370951.3 | |||
ENSG00000249209 | ENST00000429238.2 | c.442-35816T>A | intron_variant | Intron 6 of 7 | 5 | ENSP00000394107.2 |
Frequencies
GnomAD3 genomes AF: 0.0000919 AC: 14AN: 152260Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000558 AC: 14AN: 251078Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135718
GnomAD4 exome AF: 0.000228 AC: 330AN: 1444750Hom.: 0 Cov.: 27 AF XY: 0.000211 AC XY: 152AN XY: 719950
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74388
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.216T>A (p.D72E) alteration is located in exon 4 (coding exon 3) of the CRYZL1 gene. This alteration results from a T to A substitution at nucleotide position 216, causing the aspartic acid (D) at amino acid position 72 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at